03239nam a22006615i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350021001640350022001850400033002070410008002400440015002480500013002630720023002760820021002991000084003202450116004042500017005202640062005372640011005993000031006103360026006413370026006673380036006933470024007295050361007535060104011145200207012185380049014255460016014745880112014906500020016026500070016226500029016926500049017216500026017706500025017966500029018216500014018506500015018646500023018796500064019027000078019667000077020447730120021217760025022418560061022668560049023278560080023769120085024569120012025419120024025539780520321939DE-B159720240306123113.0m|||||o||d||||||||cr || ||||||||240306t20232023cau    fo  d z      eng d  a97805203219397 a10.1525/97805203219392doi  a(DE-B1597)565404  a(OCoLC)1224279006  aDE-B1597bengcDE-B1597erda0 aeng  acaucUS-CA 4aHD9665.6 7aSOC0420002bisacsh04a338.4761510917241 aSilverman, Milton M., eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aPrescriptions for Death :bThe Drugging of the Third World /cMia Lydecker, Milton M. Silverman, Philip R. Lee.  aReprint 2020 1aBerkeley, CA : bUniversity of California Press, c[2023] 4c©2023  a1 online resource (206 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda00tFrontmatter -- tCONTENTS -- tTABLES -- tPREFACE -- tA NOTE ABOUT THE AUTHORS -- t1. THE PATIENTS -- t2. THE DRUGS -- t3. THE PROFESSIONALS: PHYSICIANS, PHARMACISTS, AND OTHERS -- t4. THE DRUG INDUSTRY -- t5. BRIBERY AND OTHER STRATEGIES -- t6. THE OPTIONS -- tAPPENDIX. IFPMA CODE OF PHARMACEUTICAL MARKETING PRACTICES -- tREFERENCES -- tINDEX0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aDocuments the unregulated marketing of medications in the developing countries by drug companies based in the industrialized world, with additional information involving physicians, bribery, and profits  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 06. Mrz 2024) 0aMedical policy. 0aPharmaceutical industryxCorrupt practiceszDeveloping countries. 0aPharmaceutical industry. 0aPharmaceutical policyzDeveloping countries. 4adeveloping countries. 4agovernment policies. 4ainternational relations. 4amedicine. 4aphysician. 4apolitical science. 7aSOCIAL SCIENCE / Developing & Emerging Countries.2bisacsh1 aLee, Philip R., eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut1 aLydecker, Mia, eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut08iTitle is part of eBook package:dDe GruytertUniversity of California Press Package Archive Pre-2000z97831106353480 cprintz978052032192240uhttps://doi.org/10.1525/9780520321939?locatt=mode:legacy40uhttps://www.degruyter.com/isbn/9780520321939423Coveruhttps://www.degruyter.com/document/cover/isbn/9780520321939/original  a978-3-11-063534-8  University of California Press Package Archive Pre-2000b2000  aEBA_EMB  aGBV-deGruyter-alles